Scholarlink

Background <p>For several decades, malaria has been a significant health concern in the African region. It continues to be a major contributor to illness, hospitalizations, and death, particularly among young children and pregnant women. Despite the national and regional efforts towards achieving the 2030 malaria elimination strategy, Ethiopia still faced an increment in malaria cases. While studies exist, a thorough synthesis or mapping of practices and innovative diagnostics for Malaria was previously lacking.</p> Objective <p>To explore current practices and innovative diagnostics for Malaria in Ethiopia, 2024.</p> Method <p>This scoping review was conducted following Arksey and O’Malley’s methodological steps to develop research questions, identify relevant studies, include/exclude studies, extract data, and report the findings. To ensure methodological quality, we used the PRISMA guideline and PRISMA-ScR checklist.</p> Results <p>Thirteen studies were eligible, and 38.5% of them were published between 2008 and 2024. The majority (84.6%) of the studies were conducted using cross-sectional study designs, while one (7.7%) of them was conducted by RCT design. Most were conducted in the Amhara region (43.75%), followed by the Oromia region (31.25%). Light microscopy, rapid diagnostic test (RDT), polymerase chain reaction (PCR), and loop-mediated isothermal amplification (LAMP) were the identified malaria diagnostics so far in Ethiopia, with each having unique advantages and limitations.</p> Conclusion <p>The current study underscored the need for a tailored, highly accurate, user-friendly, and applicable diagnostics that addresses the unique limitations of each malaria diagnostic modality to support the malaria elimination and control strategy in Ethiopia.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Current practices and innovative diagnostics for Malaria in Ethiopia: a scoping review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月23日

查看全文
  • Getasew Mulat Bantie,
  • Destaw Fetene Teshome,
  • Gizew Dessie Asres,
  • Nurlign Abebe Moges,
  • Melaku Tadege,
  • Abeba Kassahun Awoke,
  • Abraham Amsalu Berneh,
  • Addisu Gasheneit Ferede,
  • Damtie Lankir Abebe,
  • Etsegenet Kindie Tiruneh,
  • Amare Alemu Melese,
  • Negese Sewagegn,
  • Gizachew Yismaw Wubetu

摘要

Background

For several decades, malaria has been a significant health concern in the African region. It continues to be a major contributor to illness, hospitalizations, and death, particularly among young children and pregnant women. Despite the national and regional efforts towards achieving the 2030 malaria elimination strategy, Ethiopia still faced an increment in malaria cases. While studies exist, a thorough synthesis or mapping of practices and innovative diagnostics for Malaria was previously lacking.

Objective

To explore current practices and innovative diagnostics for Malaria in Ethiopia, 2024.

Method

This scoping review was conducted following Arksey and O’Malley’s methodological steps to develop research questions, identify relevant studies, include/exclude studies, extract data, and report the findings. To ensure methodological quality, we used the PRISMA guideline and PRISMA-ScR checklist.

Results

Thirteen studies were eligible, and 38.5% of them were published between 2008 and 2024. The majority (84.6%) of the studies were conducted using cross-sectional study designs, while one (7.7%) of them was conducted by RCT design. Most were conducted in the Amhara region (43.75%), followed by the Oromia region (31.25%). Light microscopy, rapid diagnostic test (RDT), polymerase chain reaction (PCR), and loop-mediated isothermal amplification (LAMP) were the identified malaria diagnostics so far in Ethiopia, with each having unique advantages and limitations.

Conclusion

The current study underscored the need for a tailored, highly accurate, user-friendly, and applicable diagnostics that addresses the unique limitations of each malaria diagnostic modality to support the malaria elimination and control strategy in Ethiopia.